This CTD dossier owner and manufacturer is a global leader in generic medicines, committed to providing affordable and high-quality medications worldwide. They operate seven state-of-the-art manufacturing facilities across the globe, exporting their products to over 55 countries. Their product portfolio includes a wide range of pharmaceuticals such as tablets, capsules, liquids, injectables, ophthalmic preparations, and external preparations. They also manufacture neutraceuticals, cosmetics, veterinary medicines, and herbal products. Key therapy areas focus on cardiology, neurology, nephrology, oncology, and ophthalmology. They offer various dosage forms including oral, injectable, topical, and ophthalmic. The company holds GMP certifications and has several product patents. They have a strong presence in North America, the EU, and other regions across the globe.